JPMorgan Chase & Co. Sells 439,421 Shares of Option Care Health, Inc. $OPCH

JPMorgan Chase & Co. lessened its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 36.8% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 754,845 shares of the company’s stock after selling 439,421 shares during the period. JPMorgan Chase & Co. owned approximately 0.48% of Option Care Health worth $20,954,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Cornerstone Planning Group LLC lifted its holdings in Option Care Health by 7,621.4% during the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after acquiring an additional 1,067 shares during the period. McIlrath & Eck LLC purchased a new position in Option Care Health in the second quarter worth $37,000. Elevation Point Wealth Partners LLC bought a new position in Option Care Health in the 2nd quarter valued at $40,000. Advisory Services Network LLC purchased a new stake in shares of Option Care Health during the 3rd quarter valued at $35,000. Finally, Caitong International Asset Management Co. Ltd purchased a new stake in shares of Option Care Health during the 3rd quarter valued at $38,000. 98.05% of the stock is owned by institutional investors.

Option Care Health Price Performance

OPCH stock opened at $28.41 on Wednesday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.96 and a current ratio of 1.53. The company has a market capitalization of $4.44 billion, a price-to-earnings ratio of 22.20, a PEG ratio of 1.59 and a beta of 0.85. Option Care Health, Inc. has a fifty-two week low of $24.24 and a fifty-two week high of $36.80. The stock has a fifty day moving average of $33.08 and a 200-day moving average of $30.75.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Tuesday, February 24th. The company reported $0.46 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.46. The business had revenue of $1.47 billion for the quarter, compared to analysts’ expectations of $1.46 billion. Option Care Health had a return on equity of 18.57% and a net margin of 3.67%.The firm’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same period in the previous year, the business posted $0.44 EPS. As a group, equities research analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages recently weighed in on OPCH. Citigroup reissued an “outperform” rating on shares of Option Care Health in a report on Tuesday, January 13th. Morgan Stanley raised their price objective on shares of Option Care Health from $35.00 to $38.00 and gave the stock an “overweight” rating in a report on Tuesday, January 13th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $37.00 price objective on shares of Option Care Health in a research report on Tuesday, January 13th. Stephens upgraded shares of Option Care Health to a “strong-buy” rating in a research note on Thursday, December 11th. Finally, Wall Street Zen downgraded shares of Option Care Health from a “buy” rating to a “hold” rating in a research report on Saturday, February 28th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Option Care Health has a consensus rating of “Moderate Buy” and a consensus price target of $37.27.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.